Adjunctive immunotherapy with α-crystallin based DNA vaccination reduces Tuberculosis chemotherapy period in chronically infected mice.
about
Efficacy and Safety of Mycobacterium indicus pranii as an adjunct therapy in Category II pulmonary tuberculosis in a randomized trialLatent tuberculosis infection: myths, models, and molecular mechanismsPro- and anti-inflammatory cytokines against Rv2031 are elevated during latent tuberculosis: a study in cohorts of tuberculosis patients, household contacts and community controls in an endemic setting.Design and Construction of a Cloning Vector Containing the hspX Gene of Mycobacterium tuberculosis.A lentiviral vector-based therapeutic vaccine encoding Ag85B-Rv3425 potently increases resistance to acute tuberculosis infection in mice.Boosting with recombinant MVA expressing M. tuberculosis α-crystallin antigen augments the protection imparted by BCG against tuberculosis in guinea pigs.
P2860
Adjunctive immunotherapy with α-crystallin based DNA vaccination reduces Tuberculosis chemotherapy period in chronically infected mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Adjunctive immunotherapy with ...... in chronically infected mice.
@en
type
label
Adjunctive immunotherapy with ...... in chronically infected mice.
@en
prefLabel
Adjunctive immunotherapy with ...... in chronically infected mice.
@en
P2093
P2860
P356
P1433
P1476
Adjunctive immunotherapy with ...... in chronically infected mice.
@en
P2093
Anil K Tyagi
Priyanka Chauhan
Ruchi Jain
P2860
P2888
P356
10.1038/SREP01821
P407
P577
2013-01-01T00:00:00Z
P5875
P6179
1051302667